|
CAS-Nr. | 767340-03-4 |
Bezeichnung: | |
Englisch Name: | (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine |
Synonyma: | Sitagliptin EnaMine IMpurity;(2Z)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a];(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo-[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-t;3-AMino-1-(3-trifluoroMethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluoro-phenyl)-but-2-en-1-one;(2Z)-3-aMino-1-[3-(trifluoroMethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one;(2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one;(2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one;(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine;(Z)-3-aMino-1-(3-(trifluoroMethyl) -5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one;(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine |
CBNumber: | CB31564663 |
Summenformel: | C16H13F6N5O |
Molgewicht: | 405.3 |
MOL-Datei: | 767340-03-4.mol |
|
|
|
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine physikalisch-chemischer Eigenschaften |
|
storage temp. : |
Refrigerator |
|
|
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften White Solid |
|
Verwenden Sitagliptin intermediate. A dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension. |
|
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 41)Lieferanten |
Firmenname | Telefon | Fax | E-Mail | Land | Produktkatalog | Edge Rate |
J & K SCIENTIFIC LTD.
| -- | -- | jkinfo@jkchemical.com;market3@jkchemical.com | CHINA |
96847
|
76
|
BePharm Ltd. (Click here for a quote)
| 40068-59117; 86-21-51816456-8021/8022/8023 | +86-21-51816740 (China Mainland); +86-21-51816457 (Others) | product@bepharm.com | CHINA |
24999
|
61
|
Pure Chemistry Scientific Inc.
| 001-857-928-2050 or 1-888-588-9418 | 001-617-206-9595 | sales@chemreagents.com | USA |
9949
|
62
|
Chemfun Medical Technology(Shanghai) Co., Ltd.
| 021-67220633 & 021-37212706 | +86-21-67220638 | chemfun@chemfun.net | CHINA |
21915
|
59
|
Shanghai Longsheng chemical Co.,Ltd.
| 0086-21-58099637,58099652,58099650,58099609 To 8017,8068; 13585536065 | 0086-21-33191781 | sales@shlschem.com; bin.wu@shlschem.com;xianjun.hong@shlschem.com | CHINA |
9850
|
59
|
Nanjing Chemlin Chemical Co., Ltd
| 025-83697070; 010-68547217 | +86-25-83453306 | sales@chemlin.com.cn | CHINA |
20120
|
64
|
Chemsky(shanghai)International Co.,Ltd.
| 021-50135380 | | shchemsky@sina.com | CHINA |
32553
|
50
|
XiaoGan ShenYuan ChemPharm co,ltd
| Tell:86-712-2580635 Mobile:15527768850、 18986454762 | 86-712-2580625 QQ:1623551145 | sales02@farchem.com | CHINA |
9844
|
52
|
Wuhan Luohua Medical Technology Co.,Ltd.
| 13477084141 15327258908 | +86(27)65566697 | sales@luohuapharm.com | CHINA |
495
|
60
|
China Langchem Inc.
| 0086-21-58956006,021-58950017;021-38701807 | 0086-21-58956100 | sales@langchem.com | CHINA |
11187
|
57
|
|
|
|
|
(2Z)-2-amine -4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro][1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl] -1-(2,4,5-trifluorophenyl)but-2-en (2-4)
767340-03-4
(2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-α]pyrazin -7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
All Inhibitors
C16H13F6N5O
(2Z)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]
(2Z)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
Heterocycles
Inhibitors
Intermediates
Intermediates & Fine Chemicals
Pharmaceuticals
Pyrazine
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
3-AMino-1-(3-trifluoroMethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluoro-phenyl)-but-2-en-1-one
(2Z)-3-aMino-1-[3-(trifluoroMethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
(Z)-3-aMino-1-(3-(trifluoroMethyl) -5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
Sitagliptin EnaMine IMpurity
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo-[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-t
|